Current issue
Volume 24(2); September 2024
-
Disease modifiers and novel markers in hepatitis B virus-related hepatocellular carcinoma
Lung-Yi Mak
J Liver Cancer. 2024;24(2):145-154.
Review ArticleAugust 5, 2024
-
New systemic treatment options for advanced cholangiocarcinoma
Valentina Zanuso, Giulia Tesini, Elena Valenzi, Lorenza Rimassa
J Liver Cancer. 2024;24(2):155-170.
Review ArticleAugust 8, 2024
-
Multidisciplinary approaches to downstaging hepatocellular carcinoma: present and future
Sang-Youn Hwang, Hyunwook Choi, Wan Jeon, Ryoung-Go Kim
J Liver Cancer. 2024;24(2):171-177.
Review ArticleSeptember 5, 2024
-
Outcomes of liver resection and transarterial chemoembolization in patients with multinodular BCLC-A hepatocellular carcinoma
Jiwon Yang, Won-Mook Choi, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, et al.
J Liver Cancer. 2024;24(2):178-191.
Original ArticleApril 3, 2024
-
Inter-reader agreement for CT/MRI LI-RADS category M imaging features: a systematic review and meta-analysis
Dong Hwan Kim, Sang Hyun Choi
J Liver Cancer. 2024;24(2):192-205.
Original ArticleApril 15, 2024
-
Re-assessing the diagnostic value of the enhancing capsule in hepatocellular carcinoma imaging
Jae Seok Bae, Jeong Min Lee, Bo Yun Hur, Jeongin Yoo, Sae-Jin Park
J Liver Cancer. 2024;24(2):206-216.
Original ArticleMay 8, 2024
-
Superselective ablative chemo-ethanol embolization for recurrent single hepatocellular carcinoma: a 6-month outcome analysis
Jae Hwan Lee, Kun Yung Kim, Chong-ho Lee, Minuk Kim, Chang Jin Yoon
J Liver Cancer. 2024;24(2):217-223.
Original ArticleMay 14, 2024
-
Downstaging with atezolizumab-bevacizumab: a case series
Anand V. Kulkarni, Parthasarathy Kumaraswamy, Balachandran Menon, Anuradha Sekaran, Anuhya Rambhatla, et al.
J Liver Cancer. 2024;24(2):224-233.
Original ArticleMay 27, 2024
-
Cure can be achieved by conversion to microwave ablation following atezolizumab-bevacizumab therapy in unresectable hepatocellular carcinoma
Rene John D. Febro, Engelbert Simon S. Perillo, Akemi A. Kimura, Stephen N. Wong
J Liver Cancer. 2024;24(2):234-242.
Original ArticleJune 3, 2024
-
Role of transarterial chemoembolization for hepatocellular carcinoma with extrahepatic metastases in the era of advancing systemic therapy
Byeong Geun Song, Myung Ji Goh, Wonseok Kang, Dong Hyun Sinn, Geum-Youn Gwak, et al.
J Liver Cancer. 2024;24(2):243-252.
Original ArticleJune 3, 2024
-
Review ArticleAug 5, 2024
Disease modifiers and novel markers in hepatitis B virus-related hepatocellular carcinoma
Lung-Yi Mak
J Liver Cancer. 2024;24(2):145-154.
-
Review ArticleAug 8, 2024
New systemic treatment options for advanced cholangiocarcinoma
Valentina Zanuso, Giulia Tesini, Elena Valenzi, et al.
J Liver Cancer. 2024;24(2):155-170.
-
Review ArticleSep 5, 2024
Multidisciplinary approaches to downstaging hepatocellular carcinoma: present and future
Sang-Youn Hwang, Hyunwook Choi, Wan Jeon, et al.
J Liver Cancer. 2024;24(2):171-177.
-
Original ArticleApr 3, 2024
Outcomes of liver resection and transarterial chemoembolization in patients with multinodular BCLC-A hepatocellular carcinoma
Jiwon Yang, Won-Mook Choi, Danbi Lee, et al.
J Liver Cancer. 2024;24(2):178-191.
-
Original ArticleApr 15, 2024
Inter-reader agreement for CT/MRI LI-RADS category M imaging features: a systematic review and meta-analysis
Dong Hwan Kim, Sang Hyun Choi
J Liver Cancer. 2024;24(2):192-205.
-
Original ArticleMay 8, 2024
Re-assessing the diagnostic value of the enhancing capsule in hepatocellular carcinoma imaging
Jae Seok Bae, Jeong Min Lee, Bo Yun Hur, et al.
J Liver Cancer. 2024;24(2):206-216.
Recent Issues
-
Vol.24, No.2,
September 2024
-
Vol.24, No.1,
March 2024
-
Vol.23, No.2,
September 2023
-
Vol.23, No.1,
March 2023
-
Vol.22, No.2,
September 2022
-
Vol.22, No.1,
March 2022
-
Vol.21, No.2,
September 2021
-
Vol.21, No.1,
March 2021
-
Vol.20, No.2,
September 2020
-
Vol.20, No.1,
March 2020
TOP
E-submission
THE KOREAN LIVER CANCER ASSOCIATION
Follow JLC on Twitter